Search

Your search keyword '"Gerrit Stoter"' showing total 64 results

Search Constraints

Start Over You searched for: Author "Gerrit Stoter" Remove constraint Author: "Gerrit Stoter" Search Limiters Full Text Remove constraint Search Limiters: Full Text
64 results on '"Gerrit Stoter"'

Search Results

1. Resistance to Platinum-Containing Chemotherapy in Testicular Germ Cell Tumors Is Associated with Downregulation of the Protein Kinase SRPK1

2. Neurotoxic and neuroprotective metabolites of kynurenine in patients with renal cell carcinoma treated with interferon-α: Course and relationship with psychiatric status

Catalog

Books, media, physical & digital resources

3. Molecular profiling of platinum resistant ovarian cancer

4. A phase I and pharmacokinetic study of weekly paclitaxel and carboplatin in patients with metastatic esophageal cancer

5. IL-12: a promising adjuvant for cancer vaccination

6. Prognostic factors for survival in patients with advanced oesophageal cancer treated with cisplatin-based combination chemotherapy

7. Phase II study of bi-weekly administration of paclitaxel and cisplatin in patients with advanced oesophageal cancer

8. Inactivation of the Saccharomyces cerevisiae SKY1 gene induces a specific modification of the yeast anticancer drug sensitivity profile accompanied by a mutator phenotype

9. Interleukin 12 induces activation of fibrinolysis and coagulation in humans

10. Intrapleural administration of tumour necrosis factor-alpha (TNFα) in patients with mesothelioma: cytokine patterns and acute-phase protein response

11. Local but no systemic immunomodulation by intraperitoneal treatment of advanced ovarian cancer with autologous T lymphocytes re-targeted by a bi-specific monoclonal antibody

12. Tunnelled central venous catheters yield a low incidence of septicaemia in interleukin-2-treated patients

13. The correlation of CA15.3 and TPS with tumor course in patients with metastatic breast cancer

14. Determination of the lactone and lactone plus carboxylate forms of 9-aminocamptothecin in human plasma by sensitive high-performance liquid chromatography with fluorscence detection

15. High-dose regimen of interleukin-2 and interferon-alpha in combination with lymphokine-activated killer cells in patients with metastatic renal cell cancer

16. Sensitive high-performance liquid chromatographic fluorescence assay for the quantitation of topotecan (SKF 104864-A) and its lactone ring-opened product (hydroxy acid) in human plasma and urine

17. Modulation of immune parameters in patients with metastatic renal-cell cancer receiving combination immunotherapy (IL-2, IFNα and autologous IL-2-activated lymphocytes)

18. Imatinib mesylate (STI571) is a substrate for the breast cancer resistance protein (BCRP)/ABCG2 drug pump

19. Cisplatin, vincristine and ifosphamide combination chemotherapy of metastatic seminoma: results of EORTC trial 30874

20. Constitutive expression of the c-H-ras oncogene inhibits doxorubicin-induced apoptosis and promotes cell survival in a rhabdomyosarcoma cell line

21. Paraneoplastic ophtalmoplegia and subacute motor axonal neuropaty associated with anti-GQ1b antibodies in a patient with malignant melanoma

22. Neurotoxic and neuroprotective metabolites of kynurenine in patients with renal cell carcinoma treated with interferon-alpha: course and relationship with psychiatric status

23. Carcinoma of unknown primary: Identification of a treatable subset?

24. Analgesic adherence measurement in cancer patients: Comparison between electronic monitoring and diary

25. Impaired cisplatin influx in an A2780 mutant cell line: evidence for a putative, cis-configuration-specific, platinum influx transporter

26. Influence of pegylated interferon-alpha therapy on plasma levels of citrulline and arginine in melanoma patients

27. Subcutaneous injection of interleukin 12 induces systemic inflammatory responses in humans: implications for the use of IL-12 as vaccine adjuvant

29. Docetaxel and paclitaxel inhibit DNA-adduct formation and intracellular accumulation of cisplatin in human leukocytes

30. Phase I and pharmacokinetic study of brostallicin (PNU-166196), a new DNA minor-groove binder, administered intravenously every 3 weeks to adult patients with metastatic cancer

31. RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic response

32. Repeated administrations of interleukin (IL)-12 are associated with persistently elevated plasma levels of IL-10 and declining IFN-gamma, tumor necrosis factor-alpha, IL-6, and IL-8 responses

33. Influence of Cremophor El on the bioavailability of intraperitoneal paclitaxel

34. Structural identification and biological activity of 7-methyl-10,11-ethylenedioxy-20(S)-camptothecin, a photodegradant of lurtotecan

35. Oral piritrexim, an effective treatment for metastatic urothelial cancer

36. A dose-finding study of miltefosine (hexadecylphosphocholine) in patients with metastatic solid tumours

37. Distinct p53-independent apoptotic cell death signalling pathways in testicular germ cell tumour cell lines

38. Contents Vol. 55, 2007

39. Four cycles of BEP vs four cycles of VIP in patients with intermediate-prognosis metastatic testicular non seminoma: a randomized study of the EORTC Genitourinary Tract Cancer Cooperative Group

40. Lack of correlation between cisplatin-induced apoptosis, p53 status and expression of Bcl-2 family proteins in testicular germ cell tumour cell lines

41. Bax upregulation is an early event in cisplatin-induced apoptosis in human testicular germ-cell tumor cell line NT2, as quantitated by flow cytometry

42. Tumour marker concentration at the start of chemotherapy is a stronger predictor of treatment failure than marker half-life: a study in patients with disseminated non-seminomatous testicular cancer

43. Pharmacokinetics of the multidrug-resistance-converting drug dexniguldipine and its pyridine metabolite M-1 in the plasma, tumor, and renal tissue of tumor-bearing Wag/Rij rats

44. Determination of Irinotecan (CTP-11) and its active metabolite SN-38 in human plasma by reversed-phase high-performance liquid chromatography with fluorescence detection

45. Comparison of ethanol plasma-protein precipitation with plasma ultrafiltration and trichloroacetic acid protein precipitation for the measurement of unbound platinum concentrations

46. Randomized placebo-controlled trial of granulocyte-macrophage colony-stimulating factor in patients with chemotherapy-related febrile neutropenia

47. Modulation of multidrug resistance with dexniguldipine hydrochloride (B8509-035) in the CC531 rat colon carcinoma model

48. Inhibition of bispecific monoclonal antibody (bsAb)-targeted cytolysis by human anti-mouse antibodies in ovarian carcinoma patients treated with bsAb-targeted activated T-lymphocytes

49. Four cycles of BEP versus an alternating regime of PVB and BEP in patients with poor-prognosis metastatic testicular non-seminoma; a randomised study of the EORTC Genitoury Tract Cancer Cooperative Group

50. A phase II study of epidoxorubicin in colorectal cancer and the use of cyclosporin-A in an attempt to reverse multidrug resistance